Francis Medical Announces Strategic Financing to Accelerate Commercial Expansion and Complete Prostate Cancer Management Indication PMA Program
MAPLE GROVE, Minn., November 10, 2026 – Francis Medical, Inc., a medical device company dedicated to advancing minimally invasive therapies for urological cancers, today announced that it has entered into an agreement for financing led by Johnson & Johnson through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc (JJDC).


Refer to the device User Manual for a list of contraindications, warnings, and cautions.
Training: Do not operate the Vanquish System without completing Francis Medical-provided physician training. Untrained operation of the device may lead to improper use. Improper use can result in patient injury or equipment malfunction.